Mean overall survival gain with aflibercept plus FOLFIRI vs placebo plus FOLFIRI in patients with previously treated metastatic colorectal cancer

The use of irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer: systematic review and economic evaluation

(2014) D Hind et al.   HEALTH TECHNOLOGY ASSESSMENT

Modelling survival in hepatocellular carcinoma

(2012) Noemi Muszbek et al.   CURRENT MEDICAL RESEARCH AND OPINION

Addition of Aflibercept to Fluorouracil, Leucovorin, and Irinotecan Improves Survival in a Phase III Randomized Trial in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen

(2012) Eric Van Cutsem et al.   JOURNAL OF CLINICAL ONCOLOGY

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Cautions Regarding the Fitting and Interpretation of Survival Curves

(2011) Martin Connock et al.   PHARMACOECONOMICS

Systemic Therapy for Metastatic Colorectal Cancer: Patterns of Chemotherapy and Biologic Therapy Use in US Medical Oncology Practice

(2010) Gregory P. Hess et al.   Journal of Oncology Practice

Long-Term Survival After Colon Cancer Surgery: A Variation Associated with Choice of Anesthesia

(2009) Rose Christopherson et al.   ANESTHESIA AND ANALGESIA

Long-Term Outcome of Initially Unresectable Metastatic Colorectal Cancer Patients Treated with 5-Fluorouracil/Leucovorin, Oxaliplatin, and Irinotecan (FOLFOXIRI) Followed by Radical Surgery of Metastases

(2009) Gianluca Masi et al.   ANNALS OF SURGERY

Patients With Initially Unresectable Colorectal Liver Metastases: Is There a Possibility of Cure?

(2009) René Adam et al.   JOURNAL OF CLINICAL ONCOLOGY

Five-Year Data and Prognostic Factor Analysis of Oxaliplatin and Irinotecan Combinations for Advanced Colorectal Cancer: N9741

(2008) Hanna K. Sanoff et al.   JOURNAL OF CLINICAL ONCOLOGY